Coexpression of osteogenic and adipogenic differentiation markers in selected subpopulations of primary human mesenchymal progenitor cells

Journal of Cellular Biochemistry

Volumn 104, Issue 4, 2008, Pages 1342-1355

  Ponce, M L ^a   Koelling, S ^a   Kluever, A ^a   Heinemann, D E H ^b   Miosge, N ^a   Wulf, G ^a   Frosch, K H ^a   Schutze N ^c   Hufner, M ^a   Siggelkow, H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adipogenesis; BMP 2; Mesenchymal progenitor cells; Osteoblastic differentiation; TGF beta

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; FATTY ACID BINDING PROTEIN; LIPOPROTEIN LIPASE; OSTEOCALCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL VACUOLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOGOLD ELECTRON MICROSCOPY; MESENCHYMAL STEM CELL; MINERALIZATION; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOPENIA; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION;

ADIPOCYTES; ADIPOGENESIS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; HUMANS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENESIS;

EID: 46949087543     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21711     Document Type: Article

References (58)

1. Abdallah BM, Jensen CH, Gutierrez G, Leslie RG, Jensen TG, Kassem M. 2004. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1. J Bone Miner Res 19:841-852.
2. Ahdjoudj S, Lasmoles F, Oyajobi BO, Lomri A, Delannoy P, Marie PJ. 2001. Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multi-potential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem 81:23-38.
3. Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G. 1993. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12:871-880.
4. Bennett JH, Joyner CJ, Triffitt JT, Owen ME. 1991. Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci 99:131-139.
5. Beresford JN. 1989. Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Rel Res 240:270-295.
6. Beresford JN, Gallagher JA, Poser JW, Russell RGG. 1984. Production of osteocalcin by human bone cells in vitro. Effects of 1,25-(OH)2D3, 24,25-(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Rel Res 5:229-234.
7. Bodine PVN, Trailsmith M, Komm BS. 1996. Development and characterization of a conditionally tranformed adult human osteoblastic cell line. J Bone Miner Res 11:806-819.
8. Bowers RR, Lane MD. 2007. A role for bone morphogenetic protein-4 in adipocyte development. Cell Cycle 6:385-389.
9. Bowers RR, Kim JW, Otto TC, Lane MD. 2006. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: Role of the BMP-4 gene. Proc Natl Acad Sci USA 103:13022-13027.
10. Chang SF, Reich B, Brunzell JD, Will H. 1998. Detailed characterization of the binding site of the lipoprotein lipase-specific monoclonal antibody 5 D2. J Lipid Res 39:2350-2359.
11. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE. 1998. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142:295-305.
12. Choy L, Derynck R. 2003. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J Biol Chem 278:9609-9619.
13. Garcia T, Roman-Roman S, Jackson A, Theilhaber J, Connolly T, Spinella-Jaegle S, Kawai S, Courtois B, Bushnell S, Auberval M, Call K, Baron R. 2002. Behavior of osteoblast, adipocyte, and myoblast markers in genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone 31:205-211.
14. Gimble JM, Robinson CE, Wu X, Kelly KA. 1996. The function of adipocytes in the bone marrow stroma: An update. Bone 19:421-428.
15. Gronthos S, Stewart K, Graves SE, Hay S, Simmons PJ. 1997. Integrin expression and function on human osteoblast-like cells. J Bone Miner Res 12:1189-1197.
16. Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, Simmons PJ. 1999. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 14:47-56.
17. Gundle R, Beresford JN. 1995. The isolation and culture of cells from explants of human trabecular bone. Calcif Tissue Int 56:S8-S10.
18. Heinemann DE, Siggelkow H, Ponce LM, Viereck V, Wiese KG, Peters JH. 2000. Alkaline phosphatase expression during monocyte differentiation. Overlapping markers as a link between monocytic cells, dendritic cells, osteoclasts and osteoblasts [In Process Citation]. Immunobiology 202:68-81.
19. Hemmerich P, von Mikecz A, Neumann F, Sozeri O, Wolff-Vorbeck G, Zoebelein R, Krawinkel U. 1993. Structural and functional properties of ribosomal protein L7 from humans and rodents. Nucleic Acids Res 21:223-231.
20. Herbertson A, Aubin JE. 1997. Cell sorting enriches osteogenic populations in rat bone marrow stromal cell cultures. Bone 21:491-500.
21. Hogan BL. 1996. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594.
22. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. 2001. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165-171.
23. Köhler T. 1995. Quantification of absolute numbers of mRNA copies in a cDNA sample by competitive PCR. In: Köhler T, Laßner D, Rost AK, Thamm B, Pustowoit B, Remke H, editors. Quantification of mRNA by polymerase chain reaction - Nonradioactive PCR methods. Berlin: Springer pp 8-10.
24. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonak J, Lind K, Sindelka R, Sjoback R, Sjogreen B, Strombom L, Stahlberg A, Zoric N. 2006. The real-time polymerase chain reaction. Mol Aspects Med 27:95-125.
25. Lecanda F, Cheng SL, Shin CS, Davidson MK, Warlow P, Avioli LV, Civitelli R. 2000. Differential regulation of cadherins by dexamethasone in human osteoblastic cells. J Cell Biochem 77:499-506.
26. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
27. MacDougald OA, Mandrup S. 2002. Adipogenesis: Forces that tip the scales. Trends Endocrinol Metab 13:5-11.
28. Marie PJ, Lomri A, Sabbagh A, Basle M. 1989. Culture and behaviour of osteoblastic cells isolated from normal trabecular bone surfaces. In Vitro Cell Biol Dev 25:373-380.
29. Martinez ME, del Campo MT, Medina S, Sanchez M, Sanchez-Cabezudo MJ, Esbrit P, Martinez P, Moreno I, Rodrigo A, Garces MV, Munuera L. 1999. Influence of skeletal site of origin and donor age on osteoblastic cell growth and differentiation. Calcif Tissue Int 64:280-286.
30. Meunier P, Aaron J, Edouard C, Vignon G. 1971. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop 80:147-154.
31. Miosge N, Sasaki T, Timpl R. 1999. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. FASEB J 13:1743-1750.
32. Miosge N, Simniok T, Sprysch P, Herken R. 2003. The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo. J Histochem Cytochem 51:285-296.
33. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. 2004. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 3:379-389.
34. Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS. 2002. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20:1060-1069.
35. Noth U, Tuli R, Seghatoleslami R, Howard M, Shah A, Hall DJ, Hickok NJ, Tuan RS. 2003. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291:201-211.
36. Nutall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. 1998. Human trabecular bone cells are able to express both osteoblasic and adipocytic phenotype: Implications for osteopenic disorders. J Bone Miner Res 13:371-382.
37. Nuttall ME, Gimble JM. 2000. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27:177-184.
38. Nuttall ME, Gimble JM. 2004. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4:290-294.
39. Oreffo RO, Virdi AS, Triffitt JT. 1997. Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures. Eur J Cell Biol 74:251-261.
40. Otto TC, Bowers RR, Lane MD. 2007. BMP-4 treatment of C3H10T1/2 stem cells blocks expression of MMP-3 and MMP-13. Biochem Biophys Res Commun 353:1097-1104.
41. Owen M. 1988. Marrow stromal stem cells. J Cell Sci Suppl 10:63-76.
42. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS. 1990. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430.
43. Peterson J, Fujimoto WY, Brunzell JD. 1992. Human lipoprotein lipase: Relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies. J Lipid Res 33:1165-1170.
44. Prichett WP, Patton AJ, Field JA, Brun KA, Emery JG, Tan KB, Rieman DJ, McClung HA, Nadeau DP, Mooney JL, Suva LJ, Gowen M, Nuttall ME. 2000. Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of expiant cultures of human bone. J Cell Biochem 76:639-650.
45. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I. 1994. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218-228.
46. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. 1996. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 11:312-324.
47. Sakaguchi Y, Sekiya I, Yagishita K, Ichinose S, Shinomiya K, Muneta T. 2004. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 104:2728-2735.
48. Schilling T, Küffner R, Klein-Hitpass L, Zimmer R, Jakob F, Schütze N. 2007. Microarray analysis of transdifferentiated mesenchymal stem cells. J Cell Biochem 103:413-433.
49. Siggelkow H, Benzler K, Atkinson MJ, Hüfner M. 1998a. Phenotypic stability of primary human osteoblast-like cells at different cell densities and passage numbers. Exp Clin Endocrinol Diabetes 106:217-225.
50. Siggelkow H, Hilmes D, Rebenstorff K, Kurre W, Hüfner M. 1998b. Analysis of human primary bone cells by fluorescence activated cell scanning: Methodological problems and preliminary results. Clin Chim Acta 272:111-125.
51. Siggelkow H, Rebenstorff K, Kurre W, Niedhart C, Engel I, Schulz H, Atkinson MJ, Hufner M. 1999. Development of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 75:22-35.
52. Siggelkow H, Eidner T, Lehmann G, Viereck V, Raddatz D, Munzel U, Hein G, Hufner M. 2003. Cytokines, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone diseases. J Bone Miner Res 18:529-538.
53. Siggelkow H, Schmidt E, Hennies B, Hufner M. 2004. Evidence of downregulation of matrix extracellular phosphoglycoprotein during terminal differentiation in human osteoblasts. Bone 35:570-576.
54. Song L, Tuan RS. 2004. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 18:980-982.
55. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. 1999. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:1630-1638.
56. Thompson DL, Lum KD, Nygaard SC, Kuestner RE, Kelly KA, Gimble JM, Moore EE. 1998. The derivation and characterization of stromal cell lines from the bone marrow of p53-/- mice: New insights into osteoblast and adipocyte differentiation. J Bone Miner Res 13:195-204.
57. Tuli R, Tuli S, Nandi S, Wang ML, Alexander PG, Haleem-Smith H, Hozack WJ, Manner PA, Danielson KG, Tuan RS. 2003. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 21:681-693.
58. zur Nieden NI, Kempka G, Rancourt DE, Ahr HJ. 2005. Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: Effect of cofactors on differentiating lineages. BMC Dev Biol 5:1.